Triple agonist research peptide (GIP/GLP-1/glucagon).
Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors, studied for compound metabolic effects.
Triple agonism research shows complementary effects on glucose handling, lipid metabolism, and energy expenditure in animal studies.
Bulk: Buy 3, get 1 free
Kits (10 vials): Contact for pricing.
| Size | 15mg, 20mg, 30mg |
|---|
Important Legal Notice — Please Read
The compounds offered on this website are sold strictly for in-vitro laboratory research use only by qualified researchers. They are not intended to diagnose, treat, cure, or prevent any disease, and are not for human or animal consumption.
By entering this site you confirm that you are at least 21 years of age, that you understand these terms, and that you have a legitimate research basis for purchasing these compounds.
All compounds are sold individually. Research supplies (bacteriostatic water, syringes) are not included. Most products ship as lyophilized powder and require reconstitution with a suitable diluent prior to research use.
Reviews
There are no reviews yet.